These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 30561221)

  • 1. Scientific report: a case of acute pancreatitis due to liraglutide.
    Quesada-Vázquez N
    Rev Esp Enferm Dig; 2019 Apr; 111(4):329-330. PubMed ID: 30561221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucagon-like peptide-1 receptor agonists and risk of acute pancreatitis in patients with type 2 diabetes.
    Storgaard H; Cold F; Gluud LL; Vilsbøll T; Knop FK
    Diabetes Obes Metab; 2017 Jun; 19(6):906-908. PubMed ID: 28105738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liraglutide-induced acute pancreatitis.
    Jeyaraj S; Shetty AS; Kumar CR; Nanditha A; Krishnamoorthy S; Raghavan A; Raghavan K; Ramachandran A
    J Assoc Physicians India; 2014 Jan; 62(1):64-6. PubMed ID: 25327099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there a link between liraglutide and pancreatitis? A post hoc review of pooled and patient-level data from completed liraglutide type 2 diabetes clinical trials.
    Jensen TM; Saha K; Steinberg WM
    Diabetes Care; 2015 Jun; 38(6):1058-66. PubMed ID: 25504028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liraglutide-associated acute pancreatitis.
    Knezevich E; Crnic T; Kershaw S; Drincic A
    Am J Health Syst Pharm; 2012 Mar; 69(5):386-9. PubMed ID: 22345417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatitis: a potential complication of liraglutide?
    Franks AS; Lee PH; George CM
    Ann Pharmacother; 2012 Nov; 46(11):1547-53. PubMed ID: 23136352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute pancreatitis associated with liraglutide.
    Lee PH; Stockton MD; Franks AS
    Ann Pharmacother; 2011 Apr; 45(4):e22. PubMed ID: 21487080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse drug reactions associated with the use of liraglutide in patients with type 2 diabetes--focus on pancreatitis and pancreas cancer.
    Chalmer T; Almdal TP; Vilsbøll T; Knop FK
    Expert Opin Drug Saf; 2015 Jan; 14(1):171-80. PubMed ID: 25363438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of pancreatitis with glucagon-like peptide-1 agonist use.
    Anderson SL; Trujillo JM
    Ann Pharmacother; 2010 May; 44(5):904-9. PubMed ID: 20371755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early onset of acute pancreatitis in a patient on low-dose liraglutide.
    Chua MWJ; Ng YK
    Diabetes Metab Syndr; 2021; 15(3):753-755. PubMed ID: 33823330
    [No Abstract]   [Full Text] [Related]  

  • 11. Smoke or fire? Acute pancreatitis and the liraglutide trials.
    Gale EA
    Diabetes Care; 2015 Jun; 38(6):948-50. PubMed ID: 25998284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A meta-analysis of serious adverse events reported with exenatide and liraglutide: acute pancreatitis and cancer.
    Alves C; Batel-Marques F; Macedo AF
    Diabetes Res Clin Pract; 2012 Nov; 98(2):271-84. PubMed ID: 23010561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liraglutide-related cholelithiasis.
    Korkmaz H; Araz M; Alkan S; Akarsu E
    Aging Clin Exp Res; 2015 Oct; 27(5):751-3. PubMed ID: 25725635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucagon-like peptide-1 receptor agonists and pancreatitis: a meta-analysis of randomized clinical trials.
    Monami M; Dicembrini I; Nardini C; Fiordelli I; Mannucci E
    Diabetes Res Clin Pract; 2014 Feb; 103(2):269-75. PubMed ID: 24485345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute pancreatitis in a patient treated with liraglutide].
    Artero A; Bourguet M; Lorente RI; Real JT
    Med Clin (Barc); 2013 Oct; 141(8):368-9. PubMed ID: 23507272
    [No Abstract]   [Full Text] [Related]  

  • 16. Amylase, Lipase, and Acute Pancreatitis in People With Type 2 Diabetes Treated With Liraglutide: Results From the LEADER Randomized Trial.
    Steinberg WM; Buse JB; Ghorbani MLM; Ørsted DD; Nauck MA; ;
    Diabetes Care; 2017 Jul; 40(7):966-972. PubMed ID: 28476871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liraglutide Overdose-Induced Acute Pancreatitis.
    AlSaadoun AR; AlSaadoun TR; Al Ghumlas AK
    Cureus; 2022 Jan; 14(1):e21616. PubMed ID: 35228970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liraglutide use and evaluation of pancreatic outcomes in a US commercially insured population.
    Funch D; Mortimer K; Ziyadeh NJ; Seeger JD; Li L; Norman H; Major-Pedersen A; Bosch-Traberg H; Gydesen H; Dore DD
    Diabetes Obes Metab; 2019 Aug; 21(8):1837-1848. PubMed ID: 30945402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Off-label antiobesity treatment in patients without diabetes with GLP-1 agonists in clinical practice.
    Sauer N; Reining F; Schulze Zur Wiesch C; Burkhardt T; Aberle J
    Horm Metab Res; 2015 Jul; 47(8):560-4. PubMed ID: 25230325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GLP-1R agonist therapy for diabetes: benefits and potential risks.
    Samson SL; Garber A
    Curr Opin Endocrinol Diabetes Obes; 2013 Apr; 20(2):87-97. PubMed ID: 23403741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.